Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
- 20 May 1994
- journal article
- research article
- Published by Elsevier
- Vol. 77 (4) , 491-502
- https://doi.org/10.1016/0092-8674(94)90212-7
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Homozygous disruption of the murine MDR2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver diseasePublished by Elsevier ,1993
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993
- The Chemistry and Pharmacology of AvermectinsAnnual Review of Pharmacology and Toxicology, 1992
- A pgk::hprt fusion as a selectable marker for targeting of genes in mouse embryonic stem cells: disruption of the T-cell receptor δ-chain-encoding geneGene, 1991
- Sex‐dependent and independent expression of the P‐glycoprotein isoforms in Chinese hamsterJournal of Cellular Physiology, 1990
- Impact of Mass Treatment of Onchocerciasis with Ivermectin on the Transmission of InfectionScience, 1990
- Sequence of mdr3 cDNA encoding a human P-glycoproteinGene, 1988
- Mammalian multidrug resistance gene: Complete cDNA sequence indicates strong homology to bacterial transport proteinsCell, 1986
- Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro.Journal of Clinical Investigation, 1986
- Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeabilityJournal of Medicinal Chemistry, 1980